Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Sep;81(2):350–353. doi: 10.1038/sj.bjc.6690699

Detection of the pancreas-specific gene in the peripheral blood of patients with pancreatic carcinoma

T Kuroki 1, T Tomioka 1, Y Tajima 1, K Inoue 1, Y Ikematsu 1, K Ichinose 1, J Furui 1, T Kanematsu 1
PMCID: PMC2362854  PMID: 10496364

Abstract

The prognosis of patients with pancreatic carcinoma remains very poor. To improve the therapeutic results, the early detection of this cancer is needed. The present study was performed to detect the pancreas-specific gene, chymotrypsinogen, in the peripheral blood from patients with pancreatic carcinoma by using reverse transcription polymerase chain reaction (RT-PCR) in order to evaluate the clinical significance of this gene. Ten patients with pancreatic carcinoma, two with acute pancreatitis, three with chronic pancreatitis and ten control subjects were examined for the presence of chymotrypsinogen using RT-PCR techniques in the peripheral blood. To confirm that the chymotrypsinogen gene was expressed in a pancreas-specific manner, the expression of chymotrypsinogen in various types of human adult tissue was evaluated by RT-PCR. The specific band of the chymotrypsinogen gene was detected in the pancreas. Serial dilution studies demonstrated the chymotrypsinogen gene to be detected at a concentration of one pancreatic cell per 106 peripheral blood cells. Seven out of the ten (70%) patients with pancreatic carcinoma were found to be positive based on the RT-PCR findings. In contrast, no pancreas-specific gene was detected in the peripheral blood of any patients with acute pancreatitis, chronic pancreatitis or the control subjects. Our observations show that the detection of the pancreatic specific gene, chymotrypsinogen, is therefore useful as a genetic diagnostic marker in pancreatic carcinoma. © 1999 Cancer Research Campaign

Keywords: pancreatic carcinoma, pancreas-specific gene, reverse transcription polymerase chain reaction, peripheral blood

Full Text

The Full Text of this article is available as a PDF (93.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ajiki T., Onoyama H., Yamamoto M., Fujimori T., Maeda S., Saitoh Y. Detection of point mutations in K-ras gene at codon 12 in bile from percutaneous transhepatic choledochal drainage tubes for diagnosis of biliary strictures. Int J Pancreatol. 1995 Dec;18(3):215–220. doi: 10.1007/BF02784944. [DOI] [PubMed] [Google Scholar]
  2. Almoguera C., Shibata D., Forrester K., Martin J., Arnheim N., Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell. 1988 May 20;53(4):549–554. doi: 10.1016/0092-8674(88)90571-5. [DOI] [PubMed] [Google Scholar]
  3. Anwar K., Nakakuki K., Naiki H., Inuzuka M. ras gene mutations and HPV infection are common in human laryngeal carcinoma. Int J Cancer. 1993 Jan 2;53(1):22–28. doi: 10.1002/ijc.2910530106. [DOI] [PubMed] [Google Scholar]
  4. Bos J. L., Fearon E. R., Hamilton S. R., Verlaan-de Vries M., van Boom J. H., van der Eb A. J., Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. 1987 May 28-Jun 3Nature. 327(6120):293–297. doi: 10.1038/327293a0. [DOI] [PubMed] [Google Scholar]
  5. Bos J. L. The ras gene family and human carcinogenesis. Mutat Res. 1988 May;195(3):255–271. doi: 10.1016/0165-1110(88)90004-8. [DOI] [PubMed] [Google Scholar]
  6. Datta Y. H., Adams P. T., Drobyski W. R., Ethier S. P., Terry V. H., Roth M. S. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol. 1994 Mar;12(3):475–482. doi: 10.1200/JCO.1994.12.3.475. [DOI] [PubMed] [Google Scholar]
  7. Eltahir E. M., Mallinson D. S., Birnie G. D., Hagan C., George W. D., Purushotham A. D. Putative markers for the detection of breast carcinoma cells in blood. Br J Cancer. 1998 Apr;77(8):1203–1207. doi: 10.1038/bjc.1998.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hou D. X., Ozawa K., Tomita N., Maeda Y., Hashiguchi T., Yokoyama K., Soeda E. Genomic cloning and partial characterization of human chymotrypsinogen gene. Jpn J Hum Genet. 1993 Dec;38(4):371–380. doi: 10.1007/BF01907983. [DOI] [PubMed] [Google Scholar]
  9. Kondo H., Sugano K., Fukayama N., Kyogoku A., Nose H., Shimada K., Ohkura H., Ohtsu A., Yoshida S., Shimosato Y. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer. 1994 Mar 15;73(6):1589–1594. doi: 10.1002/1097-0142(19940315)73:6<1589::aid-cncr2820730609>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  10. Kuo M. Y., Jeng J. H., Chiang C. P., Hahn L. J. Mutations of Ki-ras oncogene codon 12 in betel quid chewing-related human oral squamous cell carcinoma in Taiwan. J Oral Pathol Med. 1994 Feb;23(2):70–74. doi: 10.1111/j.1600-0714.1994.tb00259.x. [DOI] [PubMed] [Google Scholar]
  11. Mattano L. A., Jr, Moss T. J., Emerson S. G. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res. 1992 Sep 1;52(17):4701–4705. [PubMed] [Google Scholar]
  12. Mori M., Mimori K., Inoue H., Barnard G. F., Tsuji K., Nanbara S., Ueo H., Akiyoshi T. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995 Aug 1;55(15):3417–3420. [PubMed] [Google Scholar]
  13. Motojima K., Tsunoda T., Kanematsu T., Nagata Y., Urano T., Shiku H. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene. Ann Surg. 1991 Dec;214(6):657–662. doi: 10.1097/00000658-199112000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nakanishi H., Kodera Y., Torii A., Hirai T., Yamamura Y., Kato T., Kito T., Tatematsu M. Detection of carcinoembryonic antigen-expressing free tumor cells in peritoneal washes from patients with gastric carcinoma by polymerase chain reaction. Jpn J Cancer Res. 1997 Jul;88(7):687–692. doi: 10.1111/j.1349-7006.1997.tb00437.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Noguchi S., Hiratsuka M., Furukawa H., Aihara T., Kasugai T., Tamura S., Imaoka S., Koyama H., Iwanaga T. Detection of gastric cancer micrometastases in lymph nodes by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction. Jpn J Cancer Res. 1996 Jun;87(6):650–654. doi: 10.1111/j.1349-7006.1996.tb00272.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nomoto S., Nakao A., Kasai Y., Harada A., Nonami T., Takagi H. Detection of ras gene mutations in perioperative peripheral blood with pancreatic adenocarcinoma. Jpn J Cancer Res. 1996 Aug;87(8):793–797. doi: 10.1111/j.1349-7006.1996.tb02102.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rhodes C. H., Glantz M. J., Glantz L., Lekos A., Sorenson G. D., Honsinger C., Levy N. B. A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis. Cancer. 1996 Feb 1;77(3):543–548. doi: 10.1002/(SICI)1097-0142(19960201)77:3<543::AID-CNCR17>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  18. Schoenfeld A., Luqmani Y., Smith D., O'Reilly S., Shousha S., Sinnett H. D., Coombes R. C. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res. 1994 Jun 1;54(11):2986–2990. [PubMed] [Google Scholar]
  19. Shibata D., Almoguera C., Forrester K., Dunitz J., Martin S. E., Cosgrove M. M., Perucho M., Arnheim N. Detection of c-K-ras mutations in fine needle aspirates from human pancreatic adenocarcinomas. Cancer Res. 1990 Feb 15;50(4):1279–1283. [PubMed] [Google Scholar]
  20. Smit V. T., Boot A. J., Smits A. M., Fleuren G. J., Cornelisse C. J., Bos J. L. KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res. 1988 Aug 25;16(16):7773–7782. doi: 10.1093/nar/16.16.7773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tada M., Ohashi M., Shiratori Y., Okudaira T., Komatsu Y., Kawabe T., Yoshida H., Machinami R., Kishi K., Omata M. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology. 1996 Jan;110(1):227–231. doi: 10.1053/gast.1996.v110.pm8536861. [DOI] [PubMed] [Google Scholar]
  22. Tada M., Omata M., Kawai S., Saisho H., Ohto M., Saiki R. K., Sninsky J. J. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res. 1993 Jun 1;53(11):2472–2474. [PubMed] [Google Scholar]
  23. Tada M., Omata M., Ohto M. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology. 1991 Jan;100(1):233–238. doi: 10.1016/0016-5085(91)90606-l. [DOI] [PubMed] [Google Scholar]
  24. Tomita N., Izumoto Y., Horii A., Doi S., Yokouchi H., Ogawa M., Mori T., Matsubara K. Molecular cloning and nucleotide sequence of human pancreatic prechymotrypsinogen cDNA. Biochem Biophys Res Commun. 1989 Jan 31;158(2):569–575. doi: 10.1016/s0006-291x(89)80087-7. [DOI] [PubMed] [Google Scholar]
  25. Wilentz R. E., Chung C. H., Sturm P. D., Musler A., Sohn T. A., Offerhaus G. J., Yeo C. J., Hruban R. H., Slebos R. J. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma. Cancer. 1998 Jan 1;82(1):96–103. doi: 10.1002/(sici)1097-0142(19980101)82:1<96::aid-cncr11>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  26. Yanagisawa A., Ohtake K., Ohashi K., Hori M., Kitagawa T., Sugano H., Kato Y. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res. 1993 Mar 1;53(5):953–956. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES